Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Adolescent Psychiatry
  4. Volume 14, Issue 3
  5. Article
Volume 14, Issue 3
  • ISSN: 2210-6766
  • E-ISSN: 2210-6774

Abstract

Background

Fasting in Ramadan, a holy month in Islam, is considered a religious obligation to Muslims after puberty. Fasting during Ramadan entails abstinence from consuming food and liquids, as well as abstaining from other activities, including smoking and sexual activity, from dawn until sunset. Literature exists regarding the management of multiple medical conditions impacted by the month of fasting; however, limited literature exists to guide the management of Attention-Deficit/Hyperactivity Disorder (ADHD) during Ramadan.

Methods

This systematic review employed a PUBMED search which was conducted using keywords ((ADHD) AND (Muslims)) OR ((ADHD) AND (FASTING)) OR ((ADHD) AND (RAMADAN)) OR ((RAMADAN) AND (MANAGEMENT)) and search strategies to find existing literature on ADHD management during Ramadan or while fasting.

Results

Eight hundred and sixty-one results were obtained. Of these, full texts of clinical trials, systematic reviews, reviews, randomized control trials, and meta-analyses resulted in 303 results that were screened by title or abstract for relevance to the topic. The duplicate articles were removed. Eighty-nine results were incorporated into this paper, including full articles, book excerpts, and online articles.

Discussion

Muslim adolescents may face challenges with academic and social functioning as they navigate psychosocial changes in the context of Ramadan. ADHD management options should be discussed with individuals who are planning to fast. Pharmacologic management options include continuing on the current regimen, dose adjustment to mitigate side effect exacerbation, a change in medication class, or a change in medication formulation. For severe cases or cases with comorbid conditions, continued fasting may not be recommended. In these cases, the patient should attempt to seek counsel with their community’s religious scholar in collaboration with their medication provider. Ultimately, there are limitations in the available data, and there is a need for further investigation into the impacts of fasting during Ramadan on individuals with ADHD and the effectiveness of interventions to promote treatment adherence.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aps/10.2174/0122106766298494240510052101
2024-11-01
2024-11-26

  • From This Site

    /content/journals/aps/10.2174/0122106766298494240510052101
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AbolabanH. MoujahedA.A. Muslim patients in Ramadan: A review for primary care physicians.Avicenna J. Med.201773818710.4103/ajm.AJM_76_1728791239
     [Google Scholar]
  2. AdjeiA.L. ChaudharyI. KollinsS.H. PadillaA. A pharmacokinetic study of methylphenidate hydrochloride multilayer extended-release capsules (Aptensio xr®) in preschool-aged children with attention-deficit/hyperactivity disorder.Paediatr. Drugs202022556157010.1007/s40272‑020‑00409‑z32776159
     [Google Scholar]
  3. AjabnoorG.M.A. BahijriS. ShaikN.A. BoraiA. AlamoudiA.A. Al-AamaJ.Y. ChrousosG.P. Ramadan fasting in Saudi Arabia is associated with altered expression of CLOCK, DUSP and IL-1alpha genes, as well as changes in cardiometabolic risk factors.PLoS One2017124e017434210.1371/journal.pone.017434228384165
     [Google Scholar]
  4. AkanM. UnalS. Gonenir ErbayL. TaskapanM.C. The effect of Ramadan fasting on mental health and some hormonal levels in healthy males.Egypt. J. Neurol. Psychiat. Neurosurg.20235912010.1186/s41983‑023‑00623‑9
     [Google Scholar]
  5. AkgülS. DermanO. KanburN.Ö. Fasting during ramadan: A religious factor as a possible trigger or exacerbator for eating disorders in adolescents.Int. J. Eat. Disord.201447890591010.1002/eat.2225524474707
     [Google Scholar]
  6. AkhtarA.M. GhouriN. ChahalC.A.A. PatelR. RicciF. SattarN. WaqarS. KhanjiM.Y. Ramadan fasting: Recommendations for patients with cardiovascular disease.Heart2022108425826510.1136/heartjnl‑2021‑31927333990414
     [Google Scholar]
  7. AlmaiA.M. SalpekarJ.A. Healthcare utilisation in the United Arab Emirates for children with attention-deficit hyperactivity disorder and comorbidities.BJPsych Int.2023203616310.1192/bji.2023.1437531226
     [Google Scholar]
  8. Al-RawiN. MadkourM. JahramiH. SalahatD. AlhasanF. BaHammam A. Al-Islam FarisM. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: A prospective observational study.PLoS One2020158e023792210.1371/journal.pone.023792232845924
     [Google Scholar]
  9. Al-SaediZ.S. AlharbiA.M. NmnkanyA.M. AlzubaidiB.K. AlansariA.N. AlhuzaliM. ShatlaM.M. Prevalence of attention deficit hyperactivity disorder among children in Makkah region, Saudi Arabia.Cureus2023153e3596710.7759/cureus.3596737041915
     [Google Scholar]
  10. AntshelK.M. RussoN. Autism spectrum disorders and adhd: Overlapping phenomenology, diagnostic issues, and treatment considerations.Curr. Psychiatry Rep.20192153410.1007/s11920‑019‑1020‑530903299
     [Google Scholar]
  11. AuilerJ.F. LiuK. LynchJ.M. GelotteC.K. Effect of food on early drug exposure from extended-release stimulants: Results from the Concerta, Adderall XR Food Evaluation (CAFE) Study.Curr. Med. Res. Opin.200218531131610.1185/03007990212500084012240794
     [Google Scholar]
  12. AustermanJ. ADHD and behavioral disorders: Assessment, management, and an update from DSM5.Cleve. Clin. J. Med.20158211 suppl 1) (Suppl. 1S2S710.3949/ccjm.82.s1.0126555810
     [Google Scholar]
  13. Aziz El-SayedA.A. SabetE.A. Fasting Ramadan in diabetic patients: When is fasting not advisable in a person with diabetes?J. Pak. Med. Assoc.2015655Suppl. 1S22S2526013778
     [Google Scholar]
  14. BahammamA. Does Ramadan fasting affect sleep?Int. J. Clin. Pract.200660121631163710.1111/j.1742‑1241.2005.00811.x16669826
     [Google Scholar]
  15. BeckerS.P. EpsteinJ.N. TammL. TilfordA.A. TischnerC.M. IsaacsonP.A. SimonJ.O. BeebeD.W. Shortened sleep duration causes sleepiness, inattention, and oppositionality in adolescents with attention-deficit/hyperactivity disorder: Findings from a crossover sleep restriction/extension study.J. Am. Acad. Child Adolesc. Psychiatry201958443344210.1016/j.jaac.2018.09.43930768404
     [Google Scholar]
  16. BenerA. Al QahtaniR. TeebiA.S. BessissoM. The prevalence of attention deficit hyperactivity symptoms in schoolchildren in a highly consanguineous community.Med. Princ. Pract.200817644044610.1159/00015156418836271
     [Google Scholar]
  17. BiedermanJ. BallS.W. MonuteauxM.C. SurmanC.B. JohnsonJ.L. ZeitlinS. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study.J. Dev. Behav. Pediatr.200728430230710.1097/DBP.0b013e318032791717700082
     [Google Scholar]
  18. BlochM.H. QawasmiA. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis.J. Am. Acad. Child Adolesc. Psychiatry20115010991100010.1016/j.jaac.2011.06.00821961774
     [Google Scholar]
  19. Bolea-AlamañacB. NuttD.J. AdamouM. AshersonP. BazireS. CoghillD. HealD. MüllerU. NashJ. SantoshP. SayalK. Sonuga-BarkeE. YoungS.J. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology.J. Psychopharmacol.201428317920310.1177/026988111351950924526134
     [Google Scholar]
  20. BraeckmanR. GuentherS. MickleT.C. BarrettA.C. SmithA. OhC. Dose proportionality and steady-state pharmacokinetics of serdexmethylphenidate/dexmethylphenidate, a novel prodrug combination to treat attention-deficit/hyperactivity disorder.J. Child Adolesc. Psychopharmacol.202232528829510.1089/cap.2022.001535666231
     [Google Scholar]
  21. BragazziN.L. BrikiW. KhabbacheH. RammouzI. MnadlaS. DemajT. ZouhirM. Ramadan fasting and infectious diseases: A systematic review.J. Infect. Dev. Ctries.20159111186119410.3855/jidc.581526623627
     [Google Scholar]
  22. BusheC.J. SavillN.C. Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009–2011: Focus on clinical efficacy and safety.J. Psychopharmacol.201428320421110.1177/026988111347847523438503
     [Google Scholar]
  23. Catalá-LópezF. HuttonB. Núñez-BeltránA. PageM.J. RidaoM. Macías Saint-GeronsD. CataláM.A. Tabarés-SeisdedosR. MoherD. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.PLoS One2017127e018035510.1371/journal.pone.018035528700715
     [Google Scholar]
  24. PashaM.C. PashaH.C. The cardiac patient in Ramadan.Avicenna J. Med.201662333810.4103/2231‑0770.17954727144139
     [Google Scholar]
  25. ChildressA. A critical appraisal of atomoxetine in the management of ADHD.Ther. Clin. Risk Manag.201512273910.2147/TCRM.S5927026730199
     [Google Scholar]
  26. ChildressA. Ponce De LeonB. OwensM. QuilliChew extended-release chewable tablets for the treatment of ADHD in patients ages 6 years old and above.Expert Opin. Drug Deliv.201815121263127010.1080/17425247.2018.154575930404549
     [Google Scholar]
  27. CoghillD. BanaschewskiT. CorteseS. AshersonP. BrandeisD. BuitelaarJ. DaleyD. DanckaertsM. DittmannR.W. DoepfnerM. FerrinM. HollisC. HoltmannM. ParamalaS. Sonuga-BarkeE. SoutulloC. SteinhausenH.C. Van der OordS. WongI.C.K. ZuddasA. SimonoffE. The management of ADHD in children and adolescents: Bringing evidence to the clinic: Perspective from the European ADHD Guidelines Group (EAGG).Eur. Child Adolesc. Psychiatry20233281337136110.1007/s00787‑021‑01871‑x34677682
     [Google Scholar]
  28. CohenA. AsrafK. SavelievI. DanO. HaimovI. The effects of sleep deprivation on the processing of emotional facial expressions in young adults with and without ADHD.Sci. Rep.20211111424110.1038/s41598‑021‑93641‑734244583
     [Google Scholar]
  29. ComiranE. KesslerF.H. FröehlichP.E. LimbergerR.P. Lisdexamfetamine: A pharmacokinetic review.Eur. J. Pharm. Sci.20168917217910.1016/j.ejps.2016.04.02627125257
     [Google Scholar]
  30. CorteseS. AdamoN. Del GiovaneC. Mohr-JensenC. HayesA.J. CarucciS. AtkinsonL.Z. TessariL. BanaschewskiT. CoghillD. HollisC. SimonoffE. ZuddasA. BarbuiC. PurgatoM. SteinhausenH.C. ShokranehF. XiaJ. CiprianiA. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis.Lancet Psychiatry20185972773810.1016/S2215‑0366(18)30269‑430097390
     [Google Scholar]
  31. CruzJ.P. ColetP.C. AlquwezN. InocianE.P. Al-OtaibiR.S. IslamS.M.S. Influence of religiosity and spiritual coping on health‐related quality of life in Saudi haemodialysis patients.Hemodial. Int.201721112513210.1111/hdi.1244127329681
     [Google Scholar]
  32. DonnellyG. RodriguezR. CataldoM. BhaskarS. 5. 8 comparison of adhansia xr and concerta pharmacokinetic profiles.J. Am. Acad. Child Adolesc. Psychiatry20216010S15210.1016/j.jaac.2021.09.056
     [Google Scholar]
  33. EddahbyS. KadriN. MoussaouiD. Fasting during Ramadan is associated with a higher recurrence rate in patients with bipolar disorder.World Psychiatry20141319710.1002/wps.2011324497261
     [Google Scholar]
  34. ElnadryM.H. NigmI.A. Abdel AzizI.M. ElshafeeA.M. ElazharyS.S. Abdel HafeezM.A. MohiiS.M. ElteebyD.M. Effect of Ramadan fasting on Muslim patients with chronic liver diseases.J. Egypt. Soc. Parasitol.201141233734621980772
     [Google Scholar]
  35. EmaraM.H. SolimanH.H. ElnadryM. Mohamed SaidE. Abd-ElsalamS. ElbataeH.E. ZaherT.I. EzzeldinS. BazeedS. Abdel-RazikA. Youssef MohamedS. ElfertA. Ramadan fasting and liver diseases: A review with practice advices and recommendations.Liver Int.202141343644810.1111/liv.1477533369880
     [Google Scholar]
  36. ErolA. BaylanG. YaziciF. Do Ramadan fasting restrictions alter eating behaviours?Eur. Eat. Disord. Rev.200816429730110.1002/erv.87218444254
     [Google Scholar]
  37. FaraoneS.V. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.Neurosci. Biobehav. Rev.20188725527010.1016/j.neubiorev.2018.02.00129428394
     [Google Scholar]
  38. FaraoneS.V. SergeantJ. GillbergC. BiedermanJ. The worldwide prevalence of ADHD: Is it an American condition?World Psychiatry20032210411316946911
     [Google Scholar]
  39. FarooqA. HerreraC.P. AlmudahkaF. MansourR. A prospective study of the physiological and neurobehavioral effects of ramadan fasting in preteen and teenage boys.J. Acad. Nutr. Diet.2015115688989710.1016/j.jand.2015.02.01225840939
     [Google Scholar]
  40. FernandoH. ZibelliniJ. HarrisR. SeimonR. SainsburyA. Effect of ramadan fasting on weight and body composition in healthy non-athlete adults: A systematic review and meta-analysis.Nutrients201911247810.3390/nu1102047830813495
     [Google Scholar]
  41. FindlingR.L. DinhS. Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS).CNS Drugs201428321722810.1007/s40263‑014‑0141‑y24532028
     [Google Scholar]
  42. FurqanZ. AwaadR. KurdyakP. HusainM.I. HusainN. ZaheerJ. Considerations for clinicians treating Muslim patients with psychiatric disorders during Ramadan.Lancet Psychiatry20196755655710.1016/S2215‑0366(19)30161‑031056458
     [Google Scholar]
  43. GnanavelS. SharmaP. KaushalP. HussainS. Attention deficit hyperactivity disorder and comorbidity: A review of literature.World J. Clin. Cases20197172420242610.12998/wjcc.v7.i17.242031559278
     [Google Scholar]
  44. GroomM.J. CorteseS. Current pharmacological treatments for adhd.Curr. Top. Behav. Neurosci.202257195010.1007/7854_2022_33035507282
     [Google Scholar]
  45. HaddadM. Ramadan 2023: Fasting hours and iftar times around the world.2023Retrieved October 22, 2023, from: https://www.aljazeera.com/news/2023/3/20/ramadan-2023-fasting-hours-and-iftar-times-around-the-world
  46. HassaneinM. AfandiB. Yakoob AhmedaniM. Mohammad AlamoudiR. AlawadiF. BajajH.S. BasitA. BennakhiA. El SayedA.A. HamdyO. HanifW. JabbarA. KleinebreilL. LessanN. ShaltoutI. Mohamad Wan BebakarW. AbdelgadirE. AbdoS. Al OzairiE. Al SalehY. AlaroujM. AliT. Ali AlmadaniA. Helmy Assaad-KhalilS. BashierA.M.K. Arifi BeshyahS. BuyukbeseM.A. Ahmad ChowdhuryT. Norou DiopS. Samir ElbarbaryN. ElhaddT.A. ElianaF. Ezzat FarisM. HafidhK. HusseinZ. IraqiH. KaplanW. KhanT.S. KhuntiK. MaherS. MalekR. MalikR.A. MohamedM. Sayed Kamel MohamedM. Ahmed MohamedN. PathanS. RashidF. SahayR.K. Taha SalihB. SandidM.A. ShaikhS. SlimI. TayebK. Mohd YusofB.N. Binte ZainudinS. Diabetes and Ramadan: Practical guidelines 2021.Diabetes Res. Clin. Pract.202218510918510.1016/j.diabres.2021.10918535016991
     [Google Scholar]
  47. HemamyM. PahlavaniN. AmanollahiA. IslamS.M.S. McVicarJ. AskariG. MalekahmadiM. The effect of vitamin D and magnesium supplementation on the mental health status of attention-deficit hyperactive children: A randomized controlled trial.BMC Pediatr.202121117810.1186/s12887‑021‑02631‑133865361
     [Google Scholar]
  48. HeunR. A systematic review on the effect of Ramadan on mental health: Minor effects and no harm in general, but increased risk of relapse in schizophrenia and bipolar disorder.Glob. Psychiatry20181171610.2478/gp‑2018‑0002
     [Google Scholar]
  49. HornungE. SchwerdtG. StrazzeriM. Religious practice and student performance: Evidence from Ramadan fasting.J. Econ. Behav. Organ.202320510011910.1016/j.jebo.2022.10.025
     [Google Scholar]
  50. IlicK. KuglerA.R. YanB. McNamaraN. Pharmacokinetics, safety, and tolerability of shp465 mixed amphetamine salts after administration of multiple daily doses in children aged 4–5 years with attention-deficit/hyperactivity disorder.CNS Drugs2022361718110.1007/s40263‑021‑00870‑534826114
     [Google Scholar]
  51. JahramiH.A. AlsibaiJ. ClarkC.C.T. FarisM.A.I.E. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above.Eur. J. Nutr.20205962291231610.1007/s00394‑020‑02216‑132157368
     [Google Scholar]
  52. JornayP.M. Jornay PM -- evening-dosed methylphenidate for ADHD.Med. Lett. Drugs Ther.201961157812612831386648
     [Google Scholar]
  53. KalraS. Al DeebA. SahayR. Ramadan fasting in children.J. Pak. Med. Assoc.201969574574631105303
     [Google Scholar]
  54. KollinsS.H. JainR. BramsM. SegalS. FindlingR.L. WigalS.B. KhayrallahM. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.Pediatrics20111276e1406e141310.1542/peds.2010‑126021555501
     [Google Scholar]
  55. KoushaliA.N. HajiaminiZ. EbadiA. BayatN. KhamsehF. Effect of Ramadan fasting on emotional reactions in nurses.Iran. J. Nurs. Midwifery Res.201318323223623983761
     [Google Scholar]
  56. KretchyI. Owusu-DaakuF. DanquahS. Spiritual and religious beliefs: Do they matter in the medication adherence behaviour of hypertensive patients?Biopsychosoc. Med.2013711510.1186/1751‑0759‑7‑1524138844
     [Google Scholar]
  57. KulS. SavaşE. ÖztürkZ.A. KaradağG. Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis.J. Relig. Health201453392994210.1007/s10943‑013‑9687‑023423818
     [Google Scholar]
  58. LarsonK. RussS.A. KahnR.S. HalfonN. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007.Pediatrics2011127346247010.1542/peds.2010‑016521300675
     [Google Scholar]
  59. LipkaM. Muslims and Islam: Key findings in the U.S. and around the world.2017Available From: https://www.pewresearch.org/short-reads/2017/08/09/muslims-and-islam-key-findings-in-the-u-s-and-around-the-world/
    [Google Scholar]
  60. ManeetonB. ManeetonN. SuttajitS. ReungyosJ. SrisurapanontM. MartinS. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD.Drug Des. Devel. Ther.201481685169310.2147/DDDT.S6839325336914
     [Google Scholar]
  61. MarkowitzJ.S. StraughnA.B. PatrickK.S. DeVaneC.L. PestreichL. LeeJ. WangY. MunizR. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.Clin. Pharmacokinet.200342439340110.2165/00003088‑200342040‑0000712648029
     [Google Scholar]
  62. Martinez-RagaJ. FerrerosA. KnechtC. de AlvaroR. CarabalE. Attention-deficit hyperactivity disorder medication use: Factors involved in prescribing, safety aspects and outcomes.Ther. Adv. Drug Saf.201783879910.1177/204209861667963628382197
     [Google Scholar]
  63. MayerJ.S. BrandtG.A. MeddaJ. BastenU. GrimmO. ReifA. FreitagC.M. Depressive symptoms in youth with ADHD: The role of impairments in cognitive emotion regulation.Eur. Arch. Psychiatry Clin. Neurosci.2022272579380610.1007/s00406‑022‑01382‑z35107603
     [Google Scholar]
  64. McGoughJ.J. PatakiC.S. SuddathR. Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.Expert Rev. Neurother.20055443744110.1586/14737175.5.4.43716026226
     [Google Scholar]
  65. MechlerK. BanaschewskiT. HohmannS. HägeA. Evidence-based pharmacological treatment options for ADHD in children and adolescents.Pharmacol. Ther.202223010794010.1016/j.pharmthera.2021.10794034174276
     [Google Scholar]
  66. MohamedB. Muslims are a growing presence in U.S., but still face negative views from the public. Pew Research Center.2021Retrieved October 22, 2023, from: https://www.pewresearch.org/short-reads/2021/09/01/muslims-are-a-growing-presence-in-u-s-but-still-face-negative-views-from-the-public/
  67. MTA Cooperative GroupNational Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.Pediatrics2004113475476110.1542/peds.113.4.75415060224
     [Google Scholar]
  68. MuammarT. FojasE.G.F. HelalR. LessanN. Ramadan fasting among older children and adolescents with type 1 diabetes mellitus: A real-world study from the uae.Front. Nutr.2022978667810.3389/fnut.2022.78667835399686
     [Google Scholar]
  69. MughalF. Ramadan: What it means for general practice.Br. J. Gen. Pract.20146462435610.3399/bjgp14X68060524982480
     [Google Scholar]
  70. NasserA. LiransoT. AdewoleT. FryN. HullJ.T. ChowdhryF. BusseG.D. CutlerA.J. JonesN.J. FindlingR.L. SchwabeS. A phase III, randomized, placebo-controlled trial to assess the efficacy and safety of once-daily spn-812 (Viloxazine Extended-release) in the treatment of attention-deficit/hyperactivity disorder in school-age children.Clin. Ther.20204281452146610.1016/j.clinthera.2020.05.02132723670
     [Google Scholar]
  71. NewcornJ.H. StarkJ.G. AdcockS. McMahenR. SikesC. A randomized phase I study to assess the effect of alcohol on the pharmacokinetics of an extended-release orally disintegrating tablet formulation of amphetamine in healthy adults.Clin. Ther.20173981695170510.1016/j.clinthera.2017.07.00628760535
     [Google Scholar]
  72. NuryakinC. MuchtarP.A. MassieN.W.G. HambaliS. Having exams during Ramadan: The case of Indonesia.Econ. Hum. Biol.20224710118310.1016/j.ehb.2022.10118336150255
     [Google Scholar]
  73. PalumboD.R. SalleeF.R. PelhamW.Jr BuksteinO.G. DavissW.B. McDERMOTT, M.P. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.J. Am. Acad. Child Adolesc. Psychiatry200847218018810.1097/chi.0b013e31815d9af718182963
     [Google Scholar]
  74. ParkinR. NicholasF.M. HaydenJ.C. A systematic review of interventions to enhance adherence and persistence with ADHD pharmacotherapy.J. Psychiatr. Res.202215220121810.1016/j.jpsychires.2022.05.04435753240
     [Google Scholar]
  75. PathyR. MillsK.E. GazeleyS. RidgleyA. KiranT. Health is a spiritual thing: Perspectives of health care professionals and female Somali and Bangladeshi women on the health impacts of fasting during Ramadan.Ethn. Health2011161435610.1080/13557858.2010.52378021170771
     [Google Scholar]
  76. PolanczykG.V. WillcuttE.G. SalumG.A. KielingC. RohdeL.A. ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis.Int. J. Epidemiol.201443243444210.1093/ije/dyt26124464188
     [Google Scholar]
  77. PosnerJ. PolanczykG.V. Sonuga-BarkeE. Attention-deficit hyperactivity disorder.Lancet20203951022245046210.1016/S0140‑6736(19)33004‑131982036
     [Google Scholar]
  78. RoeschB. CorcoranM. HaffeyM. StevensonA. WangP. PurkayasthaJ. MartinP. ErmerJ. Pharmacokinetics of coadministration of guanfacine extended release and methylphenidate extended release.Drugs R D.2013131536110.1007/s40268‑013‑0009‑523519656
     [Google Scholar]
  79. RokyR. ChapototF. HakkouF. BenchekrounM.T. BuguetA. Sleep during Ramadan intermittent fasting.J. Sleep Res.200110431932710.1046/j.1365‑2869.2001.00269.x11903862
     [Google Scholar]
  80. Ruiz-GoikoetxeaM. CorteseS. Aznarez-SanadoM. MagallónS. Alvarez ZalloN. LuisE.O. de Castro-ManglanoP. SoutulloC. ArrondoG. Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis.Neurosci. Biobehav. Rev.201884637110.1016/j.neubiorev.2017.11.00729162520
     [Google Scholar]
  81. SadeghiradB. MotaghipishehS. KolahdoozF. ZahediM.J. HaghdoostA.A. Islamic fasting and weight loss: A systematic review and meta-analysis.Public Health Nutr.201417239640610.1017/S136898001200504623182306
     [Google Scholar]
  82. SaletinJ.M. JackvonyS. RodriguezK.A. DicksteinD.P. A coordinate-based meta-analysis comparing brain activation between attention deficit hyperactivity disorder and total sleep deprivation.Sleep2019423zsy25110.1093/sleep/zsy25130541103
     [Google Scholar]
  83. SalleeF.R. McgoughJ. WigalT. DonahueJ. LyneA. BiedermanJ. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: A placebo-controlled trial.J. Am. Acad. Child Adolesc. Psychiatry200948215516510.1097/CHI.0b013e318191769e19106767
     [Google Scholar]
  84. SaltiI. BénardE. DetournayB. Bianchi-BiscayM. Le BrigandC. VoinetC. JabbarA. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.Diabetes Care200427102306231110.2337/diacare.27.10.230615451892
     [Google Scholar]
  85. ShawM. HodgkinsP. CaciH. YoungS. KahleJ. WoodsA.G. ArnoldL.E. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: Effects of treatment and non-treatment.BMC Med.20121019910.1186/1741‑7015‑10‑9922947230
     [Google Scholar]
  86. SteingardR. TaskiranS. ConnorD.F. MarkowitzJ.S. SteinM.A. New formulations of stimulants: An update for clinicians.J. Child Adolesc. Psychopharmacol.201929532433910.1089/cap.2019.004331038360
     [Google Scholar]
  87. StorebøO.J. Elmose AndersenM. SkoogM. Joost HansenS. SimonsenE. PedersenN. TendalB. CallesenH.E. FaltinsenE. GluudC. Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.Cochrane Libr.201920196CD00822310.1002/14651858.CD008223.pub331222721
     [Google Scholar]
  88. SwansonJ.M. Long-acting stimulants: Development and dosing.Can. Child Adolesc. Psychiatr. Rev.200514Suppl. 14919030518
     [Google Scholar]
  89. TaylorF.B. RussoJ. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder.J. Clin. Psychopharmacol.200121222322810.1097/00004714‑200104000‑0001511270920
     [Google Scholar]
  90. (a) TeoS.K. SchefflerM.R. WuA. StirlingD.I. ThomasS.D. StypinskiD. KhetaniV.D. A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.J. Clin. Pharmacol.200444217317810.1177/009127000326189914747426
     [Google Scholar]
  91. (b) WolraichM.L. HaganJ.F.Jr AllanC. ChanE. DavisonD. EarlsM. EvansS.W. FlinnS.K. FroehlichT. FrostJ. HolbrookJ.R. LehmannC.U. LessinH.R. OkechukwuK. PierceK.L. WinnerJ.D. ZurhellenW. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.Pediatrics20191444e2019252810.1542/peds.2019‑252831570648
     [Google Scholar]
/content/journals/aps/10.2174/0122106766298494240510052101
Loading
Review of Clinical Considerations in the Management of Adolescents with ADHD During Ramadan
APS 14, 117 (2024); https://doi.org/10.2174/0122106766298494240510052101
/content/journals/aps/10.2174/0122106766298494240510052101
/content/journals/aps/10.2174/0122106766298494240510052101
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): ADHD; adolescent psychiatry; fasting; islam; medications; muslims; ramadan

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test